Literature DB >> 9108437

Differentially expressed MHC class II-associated invariant chain in rat stomach pyloric mucosa with N-methyl-N-nitro-nitrosoguanidine exposure.

C Furihata1, M Oka, M Yamamoto, T Ito, M Ichinose, K Miki, M Tatematsu, Y Sakaki, K Reske.   

Abstract

Administration of N-methyl-N'-nitro-N-nitrosoguanidine, a glandular stomach carcinogen, at the concentration of 100 microg/ml in drinking water for 8 days induced the appearance of a MHC class II-associated invariant chain in the target organ of stomach pyloric mucosa of male Lewis rats. The up-regulation of the MHC class II-associated invariant chain was revealed by fluorescent differential display analysis, reverse transcription-PCR, Northern blot, and histochemical staining. The appearance of MHC class II and MHC class I was also demonstrated by reverse transcription-PCR and Northern blot. The results suggest the involvement of MHC-controlled immune reactions in chemically-induced stomach carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9108437

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Dendritic cell appearance and differentiation during early and late stages of rat stomach carcinogenesis.

Authors:  Motoi Takeuchi; Masami Yamamoto; Masae Tatematsu; Kazumasa Miki; Yoshiyuki Sakaki; Chie Furihata
Journal:  Jpn J Cancer Res       Date:  2002-08

2.  Human gastric cancer risk screening: From rat pepsinogen studies to the ABC method.

Authors:  Chie Furihata
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2021       Impact factor: 3.493

3.  Appearance of osteonectin-expressing fibroblastic cells in early rat stomach carcinogenesis and stomach tumors induced with N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  Hack-Young Maeng; Dong-Kug Choi; Motoi Takeuchi; Masami Yamamoto; Michiyo Tominaga; Tetsuya Tsukamoto; Masae Tatematsu; Takashi Ito; Yoshiyuki Sakaki; Chie Furihata
Journal:  Jpn J Cancer Res       Date:  2002-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.